These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 17223229)
1. Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4. Frerker N; Wagner L; Wolf R; Heiser U; Hoffmann T; Rahfeld JU; Schade J; Karl T; Naim HY; Alfalah M; Demuth HU; von Hörsten S Peptides; 2007 Feb; 28(2):257-68. PubMed ID: 17223229 [TBL] [Abstract][Full Text] [Related]
2. Proteolytic degradation of neuropeptide Y (NPY) from head to toe: Identification of novel NPY-cleaving peptidases and potential drug interactions in CNS and Periphery. Wagner L; Wolf R; Zeitschel U; Rossner S; Petersén Å; Leavitt BR; Kästner F; Rothermundt M; Gärtner UT; Gündel D; Schlenzig D; Frerker N; Schade J; Manhart S; Rahfeld JU; Demuth HU; von Hörsten S J Neurochem; 2015 Dec; 135(5):1019-37. PubMed ID: 26442809 [TBL] [Abstract][Full Text] [Related]
3. The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age. Dimitrijević M; Stanojević S; Mitić K; Kustrimović N; Vujić V; Miletić T; Kovacević-Jovanović V Peptides; 2008 Dec; 29(12):2179-87. PubMed ID: 18805447 [TBL] [Abstract][Full Text] [Related]
4. Outside or inside: role of the subcellular localization of DP4-like enzymes for substrate conversion and inhibitor effects. Bank U; Heimburg A; Wohlfarth A; Koch G; Nordhoff K; Julius H; Helmuth M; Breyer D; Reinhold D; Täger M; Ansorge S Biol Chem; 2011 Mar; 392(3):169-87. PubMed ID: 21194378 [TBL] [Abstract][Full Text] [Related]
5. Structural requirements for catalysis, expression, and dimerization in the CD26/DPIV gene family. Ajami K; Abbott CA; Obradovic M; Gysbers V; Kähne T; McCaughan GW; Gorrell MD Biochemistry; 2003 Jan; 42(3):694-701. PubMed ID: 12534281 [TBL] [Abstract][Full Text] [Related]
6. In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma. Jost MM; Lamerz J; Tammen H; Menzel C; De Meester I; Lambeir AM; Augustyns K; Scharpé S; Zucht HD; Rose H; Jürgens M; Schulz-Knappe P; Budde P Biochem Pharmacol; 2009 Jan; 77(2):228-37. PubMed ID: 18940185 [TBL] [Abstract][Full Text] [Related]
7. Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulation. Wagner L; Kaestner F; Wolf R; Stiller H; Heiser U; Manhart S; Hoffmann T; Rahfeld JU; Demuth HU; Rothermundt M; von Hörsten S Neuropeptides; 2016 Jun; 57():21-34. PubMed ID: 26988064 [TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of dipeptidyl peptidase 4 by targeting a substrate-specific secondary binding site. Kühn-Wache K; Bär JW; Hoffmann T; Wolf R; Rahfeld JU; Demuth HU Biol Chem; 2011 Mar; 392(3):223-31. PubMed ID: 21284559 [TBL] [Abstract][Full Text] [Related]
9. Identifying natural substrates for dipeptidyl peptidases 8 and 9 using terminal amine isotopic labeling of substrates (TAILS) reveals in vivo roles in cellular homeostasis and energy metabolism. Wilson CH; Indarto D; Doucet A; Pogson LD; Pitman MR; McNicholas K; Menz RI; Overall CM; Abbott CA J Biol Chem; 2013 May; 288(20):13936-13949. PubMed ID: 23519473 [TBL] [Abstract][Full Text] [Related]
10. Homology models of dipeptidyl peptidases 8 and 9 with a focus on loop predictions near the active site. Rummey C; Metz G Proteins; 2007 Jan; 66(1):160-71. PubMed ID: 17068815 [TBL] [Abstract][Full Text] [Related]
11. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure. Jackson EK; Dubinion JH; Mi Z Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624 [TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Gorrell MD Clin Sci (Lond); 2005 Apr; 108(4):277-92. PubMed ID: 15584901 [TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of neuropeptide Y in F344 rat substrains with a reduced dipeptidyl-peptidase IV activity. Karl T; Hoffmann T; Pabst R; von Hörsten S Pharmacol Biochem Behav; 2003 Jul; 75(4):869-79. PubMed ID: 12957230 [TBL] [Abstract][Full Text] [Related]
14. Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines. Wilson CH; Abbott CA Int J Oncol; 2012 Sep; 41(3):919-32. PubMed ID: 22736146 [TBL] [Abstract][Full Text] [Related]
15. The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26. Davoodi J; Kelly J; Gendron NH; MacKenzie AE Proteomics; 2007 Jun; 7(13):2300-10. PubMed ID: 17549790 [TBL] [Abstract][Full Text] [Related]
16. Selectivity among dipeptidyl peptidases of the S9b family. Bjelke JR; Kanstrup AB; Rasmussen HB Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(4):3-7. PubMed ID: 17543192 [TBL] [Abstract][Full Text] [Related]
17. Regulation of expression and function of dipeptidyl peptidase 4 (DP4), DP8/9, and DP10 in allergic responses of the lung in rats. Schade J; Stephan M; Schmiedl A; Wagner L; Niestroj AJ; Demuth HU; Frerker N; Klemann C; Raber KA; Pabst R; von Hörsten S J Histochem Cytochem; 2008 Feb; 56(2):147-55. PubMed ID: 17967935 [TBL] [Abstract][Full Text] [Related]
18. Identification of neuropeptide Y cleavage products in human blood to improve metabolic stability. Khan IU; Reppich R; Beck-Sickinger AG Biopolymers; 2007; 88(2):182-9. PubMed ID: 17206650 [TBL] [Abstract][Full Text] [Related]
19. Visualization of Rab3A dissociation during exocytosis: a study by total internal reflection microscopy. Lin CC; Huang CC; Lin KH; Cheng KH; Yang DM; Tsai YS; Ong RY; Huang YN; Kao LS J Cell Physiol; 2007 May; 211(2):316-26. PubMed ID: 17149709 [TBL] [Abstract][Full Text] [Related]
20. The effect of CD26-deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease. Buljevic S; Detel D; Pugel EP; Varljen J J Cell Biochem; 2018 Aug; 119(8):6743-6755. PubMed ID: 29693275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]